Dr. Albitar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
175 Technology Dr.
Irvine, CA 92618Phone+1 657-202-5950Fax+1 949-301-9719
Education & Training
- Damascus University Faculty of MedicineClass of 1979
Certifications & Licensure
- CA State Medical License 2003 - 2027
- DC State Medical License 2023 - 2027
- FL State Medical License 2017 - 2027
- CT State Medical License 2023 - 2026
- MD State Medical License 2023 - 2026
- PA State Medical License 1986 - 2026
- RI State Medical License 1984 - 2026
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- Join now to see all
Publications & Presentations
PubMed
- Prospective validation study of a combined urine and plasma test for predicting high-grade prostate cancer in biopsy naïve men.Torben Brøchner Pedersen, Mads Hvid Poulsen, Martin Lund, Søren Feddersen, Maher Albitar
Scandinavian Journal of Urology. 2025-01-14 - 9 citationsIndolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy.Metin Ozdemirli, Thomas M Loughney, Emre Deniz, Joeffrey J Chahine, Maher Albitar
The New England Journal of Medicine. 2024-06-13 - 1 citationsUsing Targeted Transcriptome and Machine Learning of Pre- and Post-Transplant Bone Marrow Samples to Predict Acute Graft-versus-Host Disease and Overall Survival after...Scott D Rowley, Thomas S Gunning, Michael Pelliccia, Alexandra Della Pia, Albert Lee
Cancers. 2024-03-29
Press Mentions
- Genomic Testing Cooperative and Its Co-Op Members First to Use Artificial Intelligence to Distinguish Between 45 Hematologic and Solid Neoplasms Using Targeted TranscriptomeOctober 13th, 2022
- CorePath Laboratories Internalizes Genomic Testing Cooperative's State-of-the-Art Next-Generation Sequencing (NGS) Testing for Solid Tumors and Hematologic NeoplasmsMay 16th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: